Why the study?
Do thiazide diuretics reduce the risk of stroke in hypertensive patients without manifest cardiovascular disease?
Do thiazide diuretics reduce the risk of stroke in hypertensive patients without manifest cardiovascular disease?
Low-dose thiazide diuretics may offer specific cerebroprotective benefits against stroke in hypertensive patients, independent of their blood pressure-lowering effects.
Answers are grounded in this paper and cite their sources.
May favor thiazides for stroke prevention in hypertension; leaves open causal confirmation in randomized trials.
Several large studies have suggested that therapy with thiazide diuretics confers a particular benefit in reducing the risk of strokes that seem to be, at least to some extent, independent of the blood pressure-lowering effect. Such a cerebroprotective effect was documented not only with monotherapy but also when diuretics were used in combination with other drugs. The cerebroprotective effect does not seem to be shared by other drug classes, such as the beta-blockers or the angiotensin-converting enzyme inhibitors, in patients without manifest cardiovascular disease. Since stroke is one of the most devastating sequelae of high blood pressure, our data strongly favor the use of low-dose diuretics either as initial therapy or in combination in all hypertensive patients at risk for cerebrovascular disease.
No takes yet. Share an insight, caveat, or question.
Messerli et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: